Bioventus is a global leader of active orthopaedic healing, providing clinically proven and cost-effective therapies and diagnostics that help patients regain active lifestyles. The company's innovative products include the market-leading bone stimulation device and osteoarthritis joint fluid therapies. Bioventus' adherence to high quality standards, its commitment to evidence-based medicine and its strong ethical behavior makes it a trusted partner for physicians worldwide.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/07/12 | undisclosed |
Essex Woodlands Smith & Nephew | undisclosed |
